All-E-lutein

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• age-related cognitive decline [Insufficient Evidence]
• age-related macular degeneration [Possibly Effective]
• Alzheimer dz [Insufficient Evidence]
• amyotrophic lateral sclerosis [Insufficient Evidence]
• asthenopia (eye strain) [Insufficient Evidence]
• asthma [Insufficient Evidence]
• bronchopulmonary dysplasia [Possibly Ineffective]
• cancer prevention, cervical [Insufficient Evidence]
• cancer prevention, colorectal [Insufficient Evidence]
• cancer prevention, esophageal [Insufficient Evidence]
• cancer prevention, gastric [Insufficient Evidence]
• cancer prevention, lung [Insufficient Evidence]
• cancer prevention, pancreatic [Insufficient Evidence]
• cardiovascular dz prevention [Insufficient Evidence]
• cataracts [Possibly Effective]
• central serous retinopathy [Insufficient Evidence]
• child development [Insufficient Evidence]
• choroideremia [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• depression [Insufficient Evidence]
• diabetes [Insufficient Evidence]
• diabetic retinopathy [Insufficient Evidence]
• exercise-induced muscle soreness [Insufficient Evidence]
• fracture [Insufficient Evidence]
• glaucoma [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• infertility [Insufficient Evidence]
• macular telangiectasia type 2 [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• myopia [Insufficient Evidence]
• necrotizing enterocolitis prevention [Possibly Ineffective]
• non-Hodgkin lymphoma [Insufficient Evidence]
• obesity [Insufficient Evidence]
• Parkinson dz [Insufficient Evidence]
• pre-eclampsia [Insufficient Evidence]
• respiratory infections [Insufficient Evidence]
• retinitis pigmentosa [Possibly Ineffective]
• retinopathy of prematurity [Possibly Ineffective]
• ulcerative colitis [Insufficient Evidence]
• visual development [Insufficient Evidence]